ACE and chronic kidney disease: In addition, the observed changes in endogenous antioxidant systems may be disturbed by the implemented pharmacological treatment (pro-oxidant iron or antioxidant ACE inhibitors), increased ferritin level as well as may also result from hypofunctions of salivary glands during CKD.